Pay in 4 interest-free payments of $223.75 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
exhibits low activity on IFN-γ/STAT1 and IL-6/STAT3 signaling pathways with inhibition ratio of 5
Dihydroartemisinin induces autophagy by suppressing NF-κB activation
cattle and other non-human mammals
p300 and CBP are transcriptional co-activators that modulate DNA replication
Etanercept roxymethyl-2-furancarboxylic acid exhibits low activity on IFN-γ/STAT1Etanercept, a dimeric fusion protein that binds TNF, acts as a TNF inhibitor. Etanercept competitively inhibits the binding of both TNF and TNF to cell surface TNF receptors, rendering TNF biologically inactive. Etanercept shows efficacy against rheumatoid arthritis, juvenile idiopathic arthritis, and plaque psoriasis. Product information CAS Number: 185243 69 0 Technical Data Appearance: Solid Power Purity: 98% (or refer to the Certificate of
US$ 811.50
US$ 530.00
US$ 745.50
US$ 911.50
US$ 1044.00
US$ 646.00
US$ 712.50
US$ 629.50
US$ 45.00
US$ 977.50
US$ 50.00
US$ 20.00
US$ 911.50
US$ 1507.50
US$ 35.00